… surgical strategies for treating unruptured brain aneurysms … Clinical Research Center for Neurological Diseases, Beijing, China. The … ChTUIA; we’re developing an entire decision- … Chinese Population: China Treatment Trial for Unruptured Intracranial Aneurysm …

… the Food and Drug Administration (FDA) to ban mercury … nasal sprays, ear drops, medications, and most recently, vaccines … 26, 2025). The FDA’s 2020 guidance specifically … of age Individuals with neurological disorders, including multiple sclerosis, …

… instability, psychiatric or neurological disorders, or alcohol abuse; … of the study medications. In addition, … controlled trial comparing remimazolam with propofol. Drug Des … , Galanopoulou AS. Developmental pharmacology of benzodiazepines under normal …

… FDA approved fremanezumab‑vfrm (Ajovy; Teva Pharmaceuticals) injection for the preventive treatment … neurological disorder among children and adolescents. The FDA’ … from the SPACE trial, which enrolled 237 … : FDA Approves Drug for the Preventive Treatment of …

… disease, is an incurable neurological disorder affecting motor neurons—nerve … provide clues for potentially treating the devastating disorder … a promising step toward future treatments,” she said. “That’ … medications approved for ALS by the U.S. Food and Drug …

… National Institute of Neurological Disorders and Stroke. … quality of life. Treatment approaches include disease … ocrelizumab, and alemtuzumab. Treating relapses: Corticosteroids: Intravenous … Pain management: Various medications like amitriptyline, pregabalin …

… based AI-powered drug researcher XTalPi jumped as … rights to develop and commercialise drug candidates discovered … and inflammatory diseases, neurological disorders and metabolic dysregulation,” XTalPi … The company’s self-developed large language model (LLM …

… disease, is an incurable neurological disorder affecting motor neurons—nerve … provide clues for potentially treating the devastating disorder … a promising step toward future treatments,” she said. “That’ … medications approved for ALS by the U.S. Food and Drug …

… authorization aimed at the treatment of patients with avanced … from healthy donors were developed into the precursors of … Sumitomo Pharma is also carrying out a clinical trial in the … is a chronic, degenerative neurological disorder that affects the body…

… major hurdle for treatment. Current medications targeting serotonin receptors … MAOB inhibitor" developed at IBS, the mice … drug is currently undergoing Phase 2 trials for other neurological disorders … also be useful for treating other disorders involving …